The Jackson Laboratory announces Gilbane Building Co. as program manager for Connecticut facility

Gilbane to manage program for new genomic medicine facility that will create 300 jobs in Connecticut.

February 14, 2012 |
JAX Genomic Medicine, a new nonprofit institute for genomics-based personalized

Jackson Laboratory officials announced that Gilbane Building Co. of Glastonbury, Conn. has been selected as program manager for The Jackson Laboratory’s proposed genomic medicine facility in Farmington, Conn.

JAX Genomic Medicine, a new nonprofit institute for genomics-based personalized medicine, will be built on a 17-acre site on the UConn Health Center campus in Farmington. Initial operations will begin this year in leased space while a 173,000-square-foot permanent facility is designed and built. Construction will begin in 2013, and the new facility will open in 2014. It will house 300 biomedical researchers, technicians and support staff in state-of-the-art computing facilities and laboratories.

Gilbane has specialized expertise in both the program management and construction of multi-faceted research and life-science buildings, including the UConn Pharmacy Laboratory, various research facilities at Pfizer and Bayer along with the new Centers for Disease Control & Prevention Public Health Laboratory and the NIH National Institute of Allergy and Infectious Diseases Integrated Research Facility.

The Jackson Laboratory is an independent, nonprofit biomedical research institution and National Cancer Institute-designated Cancer Center based in Bar Harbor, Maine, with a facility in Sacramento, Calif., a future institute in Farmington, Conn., and a total staff of about 1,400. Its mission is to discover the genetic basis for preventing, treating and curing human disease, and to enable research and education for the global biomedical community. BD+C

Overlay Init